Literature DB >> 16000307

Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.

Ulrike Sommer1, Christine Schmid, Radoslaw M Sobota, Ute Lehmann, Nigel J Stevenson, James A Johnston, Fred Schaper, Peter C Heinrich, Serge Haan.   

Abstract

The suppressors of cytokine signaling (SOCS) are negative feedback inhibitors of cytokine signal transduction. SOCS3 is a key negative regulator of interleuking-6 (IL-6) signal transduction. Furthermore, SOCS3 was shown to be phosphorylated upon treatment of cells with IL-2, and this has been reported to regulate its function and half-life. We set out to investigate whether SOCS3 phosphorylation may play a role in IL-6 signaling. Tyrosine-phosphorylated SOCS3 was detected upon treatment of mouse embryonic fibroblasts with IL-6. Interestingly, the observed SOCS3 phosphorylation does not require SOCS3 recruitment to phosphotyrosine (Tyr(P)) 759 of gp130, and the kinetics of SOCS3 phosphorylation do not match the activation kinetics of the Janus kinases. This suggests that other kinases may be involved in SOCS3 phosphorylation. Using Src and Janus kinase inhibitors as well as Src kinase-deficient mouse embryonic fibroblasts, we provide evidence that Src kinases, which we found to be constitutively active in these cells, are involved in the phosphorylation of IL-6-induced SOCS3. In addition, we found that receptor-tyrosine kinases such as platelet-derived growth factor receptor or epidermal growth factor receptor can very potently phosphorylate IL-6-induced SOCS3. Taken together, these results suggest that SOCS3 phosphorylation is not a JAK-mediated phenomenon but is dependent on the activity of other kinases such as Src kinases or receptor-tyrosine kinases, which can either be constitutively active or activated by an additional stimulus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000307     DOI: 10.1074/jbc.M506008200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases.

Authors:  Joanne Elliott; Yvonne Suessmuth; Linda M Scott; Krystyna Nahlik; Mary Frances McMullin; Stefan N Constantinescu; Anthony R Green; James A Johnston
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

2.  Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.

Authors:  William A Sands; Hayley D Woolson; Gillian R Milne; Claire Rutherford; Timothy M Palmer
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.

Authors:  Jargalsaikhan Dagvadorj; Yoshikazu Naiki; Gantsetseg Tumurkhuu; Abu Shadat Mohammod Noman; Imtiaz Iftakhar-E-Khuda; Takayuki Komatsu; Naoki Koide; Tomoaki Yoshida
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

Review 4.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

5.  SOCS3 deficiency promotes M1 macrophage polarization and inflammation.

Authors:  Hongwei Qin; Andrew T Holdbrooks; Yudong Liu; Stephanie L Reynolds; Lora L Yanagisawa; Etty N Benveniste
Journal:  J Immunol       Date:  2012-08-27       Impact factor: 5.422

6.  Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk.

Authors:  Brian Thomas Joyce; Tao Gao; Lei Liu; Yinan Zheng; Siran Liu; Wei Zhang; Frank Penedo; Qi Dai; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-11       Impact factor: 4.254

7.  Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.

Authors:  Jamie J L Williams; Kirsten M A Munro; Timothy M Palmer
Journal:  Cells       Date:  2014-05-30       Impact factor: 6.600

8.  Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke.

Authors:  Sabina Halappanavar; Marsha Russell; Martin R Stampfli; Andrew Williams; Carole L Yauk
Journal:  BMC Med Genomics       Date:  2009-08-21       Impact factor: 3.063

9.  Reduced IL-10 production in fetal type II epithelial cells exposed to mechanical stretch is mediated via activation of IL-6-SOCS3 signaling pathway.

Authors:  Michael A Hokenson; Yulian Wang; Renda L Hawwa; Zheping Huang; Surendra Sharma; Juan Sanchez-Esteban
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody.

Authors:  Angélique Gougelet; Adeline Mansuy; Jean-Yves Blay; Laurent Alberti; Claudine Vermot-Desroches
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.